UF/IFAS Awards $524K to Research Teams To Drive Agricultural Innovation (UF/IFAS)
UF researchers were selected as recipients of the 2026 SEEDIT funding program, supporting innovative research to address emerging agricultural challenges.
Tech Tuesday: University of Florida Team Researches Environmental Impact of Water-Soluble Polymers (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate spotlights UF research on the biodegradation and environmental fate of water-soluble polymers that are widely released into soil and other ecosystems.
UF Researchers Collaborate With NASA’s Deep Space Logistics Team To Reduce and Repurpose Mission Waste (UF News)
UF researchers are collaborating with NASA to develop biomanufacturing methods that use cells and enzymes to recycle space mission packaging waste into useful materials, supporting more sustainable long-duration space missions.
Solid Biosciences Doses First Patient in Phase 1b FALCON Trial for Friedreich’s Ataxia (Solid Biosciences)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced that the first participant has been dosed in FALCON, the Company’s Phase 1b, first-in-human clinical trial evaluating SGT-212, its investigational gene therapy for the treatment of Friedreich’s ataxia (FA).
UF/IFAS Awards $321K in AI Grants To Advance Ag-Tech Industry (UF/IFAS)
Five UF research teams were selected as recipients of the 2026 Launching Innovative Faculty Teams in AI funding program to advance AI research in agriculture.
New Drug Delivery Mechanism Could Aid Breast Cancer Treatment (UF Pharmacy)
UF researchers have found a way to make treatment for a notoriously aggressive breast cancer more effective in a study published in the Journal of Extracellular Vesicles.
HiPerGator Supercomputer Accelerates Diabetes Drug Discovery (UF Health)
Using a blend of computer modeling, structural and cell-based studies, UF researchers have designed a group of potential diabetes drugs that reprogram insulin-resistant cells into a healthier state while limiting side effect risks of older medications.
Atsena Completes Part B Dosing and Advances to Pivotal Part C of LIGHTHOUSE Trial (Atsena Therapeutics)
UF startup Atsena Therapeutics announced that dosing is complete in patients enrolled across all adult and pediatric cohorts in Part B of the Phase I/II/III Lighthouse Trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Trilateral Global Research Partnership in Marine Natural Products May Trigger New Wave of Drug Discovery (UF Pharmacy)
A global partnership led by the University of Florida’s CNPD3 with Duke-NUS Medical School and Indonesia’s BRIN seeks to harness Indonesia’s exceptional marine biodiversity to discover and develop novel medicines and therapeutic products.
Dr. Stephan Schmidt Named Chair of the Department of Pharmaceutics (UF Pharmacy)
UF researcher Stephan Schmidt, Ph.D., F.C.P., has been appointed chair of the Department of Pharmaceutics in the University of Florida College of Pharmacy.